¿Es palmitoyl tetrapeptide-50 seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR reproductive/toxicity flags located, and no peer‑reviewed reproductive toxicity or human teratogenicity data identified in database searches (PubMed, PubChem, CosIng, ECHA dossiers). CIR/SCCS-style sources do not indicate reproductive hazard, so default hazard/mechanism scores are 0. Exposure from topical cosmetic use is expected to be negligible for reproductive systemic effect in adults.
Pregnancy-safe products containing palmitoyl tetrapeptide-50










Related ingredients
Frequently asked questions
- ¿Es palmitoyl tetrapeptide-50 seguro durante el embarazo?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR reproductive/toxicity flags located, and no peer‑reviewed reproductive toxicity or human teratogenicity data identified in database searches (PubMed, PubChem, CosIng, ECHA dossiers). CIR/SCCS-style sources do not indicate reproductive hazard, so default hazard/mechanism scores are 0. Exposure from topical cosmetic use is expected to be negligible for reproductive systemic effect in adults.
- ¿Es palmitoyl tetrapeptide-50 seguro durante la lactancia?
- No evidence of reproductive or lactation-specific toxicity in available regulatory/peer‑reviewed sources (ECHA, PubMed, CosIng, EWG). Given lack of systemic toxicity data and expected low systemic absorption after topical use, breastfeeding hazard and mechanism are scored 0 and exposure is considered negligible for causing breastmilk-mediated effects.
- ¿Es palmitoyl tetrapeptide-50 seguro para la piel del bebé?
- No infant-specific toxicity or developmental effects identified. Peptides (even palmitoylated) are relatively large molecules and literature/regulatory sources do not report reproductive or developmental toxicity, so hazard/mechanism remain 0. Because infant skin has higher permeability and surface-area-to-weight, exposure score is increased by +1 relative to adults (from negligible to low/measurable), although no data indicate systemic harm.
- ¿Cómo puntúa VeriMom a palmitoyl tetrapeptide-50?
- VeriMom puntúa palmitoyl tetrapeptide-50 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a palmitoyl tetrapeptide-50 en el embarazo?
- Consulta nuestra lista de alternativas seguras a palmitoyl tetrapeptide-50 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.